Using Biomarkers to Characterize 
Human Benzene Metabolism
S. M. Rappaport
Schools of Public Health
University of North Carolina, Chapel Hill
University of California, Berkeley
Supported by grant P42ES10126 from the National 
Institute for Environmental Health Sciences and a contract 
from the Health Effects Institute
S. M. Rappaport
2
Benzene
•
 
Human carcinogen
–
 
First linked with bone marrow toxicity in 1896 
(Santesson, C. Arch Hyg Berl 31: 337) and with 
leukemia in 1928 Delore, P. and Borgomano, C. J Med 
Lyon 9: 227)
–
 
Dose-response poorly defined 
–
 
Uncertain risks, particularly at low exposures
•
 
Mechanism not completely understood 
–
 
Linked to metabolism
•
 
Metabolism is complex 
–
 
Qualitatively similar in all mammals 
–
 
Important quantitative differences among species
–
 
Can be affected by genetics (SNPs)
•
 
Dose-related metabolism poorly characterized in 
humans
S. M. Rappaport
3
benzene
O
N
S
CH3
C
CH
CH2
COOH
Oxepin
O
conjugate
via GST
S-phenylmercapturic acid
COOH
HOOC
CHO
OCH
E,E-Muconic Acid
OH
Phenol
OH
Hydroquinone
O
O
1,4-Benzoquinone
OH
OH
HO
OH
OH
Catechol
O
OH
OH
Benzene Diol Expoxide
O
O
Benzene dihydrodiol
OH
1,2-Benzoquinone
CYP
CYP2E1
Nonezymatic 
Rearrangement
Epoxide Hydrolase
CYP
dihyrodiol dehydrogenase
CYP2E1
HO
OH
E,E-Muconaldehyde
1,2,4-trihydroxybenzene
O
Benzene Oxide
CYP2E1
Benzene Metabolism
4
Benzene Biomarkers Among 
Chinese Workers
Rothman et al., PNAS, 1995
Rothman et al., AJIM, 1996
Rothman et al., EHP 1996
Rothman et al., Cancer Res, 1997
Rothman et al., OEM, 1998
Smith et al., Cancer Res, 1998
Smith et al., PNAS, 2000
Yeowell-O’Connell et al., Carcinogenesis, 1998
Yeowell-O’Connell et al., CEBP, 2001
Waidyanatha et al., Carcinogenesis, 2001
Waidyanatha et al., Analyt Biochem, 2004
Rappaport et al., J Chromatog B, 2002
STUDY #1 (NCI, UC-Berkeley, UNC)
44 Exposed subjects and 44 controls 
in Shanghai, China
• 
Very high exposure (med. = 31 ppm)
• 
Focus on hematology and cytogenetics
• 
Developed and validated biomarkers of 
exposure (protein adducts, urinary 
benzene, and urinary metabolites)
• 
Evidence of saturable metabolism
5
Benzene Biomarkers Among 
Chinese Workers
Qu et al., AJIM, 2000
Qu et al., AJIM, 2002
Melikian et al., J Chromatog (B), 2002
Rappaport et al., Cancer Res, 2002
STUDY #2
134 Exposed subjects and 
51 controls in Tianjin, 
China
Lower exposure (med. = 3.1 
ppm)
• 
Focus upon hematology 
and biomarkers of 
exposure
0
500
1000
1500
2000
0
10
20
30
40
50
Benzene, ppm
B O-A lb, pmol/g
6
Benzene in Air and BO-Alb
 
Adducts
 
(STUDY #2)
Rappaport, et al., Cancer Res, 62: 1330-1337 (2002).
Saturation of benzene 
metabolism beginning at 
about 1 ppm (much lower than 
previously suggested)
Greater unit risk at low 
exposure levels
Motivated EPA to reduce 
benzene content in gasoline 
(2007)
CAN THIS FINDING BE 
VERIFIED?
10-fold 
reduction in 
slope
S. M. Rappaport
7
Vermeulen et al., Ann Occup Hyg, 2004
Lan et al., Science, 2004
Lan et al., Zhang et al., Chem-Biol Interact, 2005
Lan et al., Cancer Res, 2005
Vermeulen et al., PNAS, 2005
Chen et al., Carcinogenesis, 2006
Kim et al., Carcinogenesis, 2006
Kim et al., CEBP, 2006
Kim et al., PGEN, in press
Benzene Biomarkers Among Chinese 
Workers
STUDY #3 (NCI, UC-Berkeley, UNC)
250 Exposed subjects and 140 
controls in Tianjin, China
• 
Similar exposures (med. = 3.7 
ppm)
• 
Focus on exposure-biomarker 
relationships and mechanism
S. M. Rappaport
8
benzene
O
N
S
CH3
C
CH
CH2
COOH
Oxepin
O
conjugate
via GST
S-phenylmercapturic acid
COOH
HOOC
CHO
OCH
E,E-Muconic Acid
OH
Phenol
OH
Hydroquinone
OH
OH
Catechol
O
OH
OH
Benzene Diol Expoxide
Benzene dihydrodiol
OH
CYP
CYP2E1
Nonezymatic 
Rearrangement
Epoxide Hydrolase
CYP
dihyrodiol dehydrogenase
HO
OH
E,E-Muconaldehyde
O
Benzene Oxide
CYP2E1
Air Samples (n=2783) and Urinary 
Analytes (n=620)
Air; Unmetabolized benzene in 
urine
Major metabolites 
(99% of absorbed 
dose)
Minor metabolite
S. M. Rappaport
9
Urinary Benzene vs. Exposure
0.1
1
10
100
1
10
100
1000
10000
100000
1000000
urinary benzene, nmol/l
air benzene, ppm
LOD for air monitors
Urinary benzene detected in all exposed AND
 
control subjects –
 
Used to predict benzene 
exposures in controls
0.01
0.1
1
10
100
1
10
100
1000
10000
100000
urinary benzene, nmol/l
air benzene, ppm
B.
0.01
0.1
1
10
100
1
10
100
1000
10000
100000
urinary benzene, nmol/l
air benzene, ppm
B.
Tianjin workers
Italian workers
(Ghittori et al., 1993)
Kim et al., Carcinogenesis, 27:772 (2006)
S. M. Rappaport
10
Metabolites vs. Exposure
 
(Groups of 30 Workers)
 
A. MA
B. SPMA
D. CA
C. PH
E. HQ
Urinary metabolites not 
useful for monitoring 
environmental exposures 
to benzene due to 
background sources 
(other than benzene)
Sig. increase above 
background levels
Kim et al., Carcinogenesis, 27:772 (2006)
S. M. Rappaport
11
Dose-specific Metabolism
1
10
100
0.01
0.1
1
10
100
air benzene, ppm
M A/ b en z en e, μm o l/ l/ p p m
0.01
0.1
1
0.01
0.1
1
10
100
air benzene, ppm
SPM A/ benz ene, μm ol/ l/ ppm
1
10
100
1000
0.01
0.1
1
10
100
air benzene, ppm
PH/ benzene, μmol/ l/ ppm
1
10
100
1000
0.01
0.1
1
10
100
air benzene, ppm
CA/ b en z en e, μm o l/ l/ p p m
1
10
100
0.01
0.1
1
10
100
air benzene, ppm
H Q / b en z en e, μm o l/ l/ p p m
1
10
100
1000
10000
0.01
0.1
1
10
100
air benzene, ppm
To tal/ b en z en e, μm o l/ l/ p p m
A. MA
B. SPMA
D. CA
C. PH
E. HQ
F. Total
Groups (n = 30) after 
adjustment for 
background levels
•
 
Reduced production of 
major & total metabolites 
at low exposures (0.01 –
 
1 
ppm, never reported 
previously)
Kim et al., Carcinogenesis, 
27:772 (2006)
S. M. Rappaport
12
Modeling Metabolite Levels
 
(Natural Splines)
 
Air benzene, ppm
0.001
0.01
0.1
1
10
100
Concentration of MA, μM
0.01
0.1
1
10
100
1000
10000
Air benzene, ppm
0.001
0.01
0.1
1
10
100
Concentration of SPMA, μM
0.0001
0.001
0.01
0.1
1
10
100
1000
Air benzene, ppm
0.001
0.01
0.1
1
10
100
Concentration of PH, μM
1
10
100
1000
10000
Air benzene, ppm
0.001
0.01
0.1
1
10
100
Concentration of CA, μM
1
10
100
1000
A. MA
B. SPMA
C. PH
D. CA
Air benzene, ppm
0.001
0.01
0.1
1
10
100
Concentration of MA, μM
0.01
0.1
1
10
100
1000
10000
Air benzene, ppm
0.001
0.01
0.1
1
10
100
Concentration of SPMA, μM
0.0001
0.001
0.01
0.1
1
10
100
1000
Air benzene, ppm
0.001
0.01
0.1
1
10
100
Concentration of PH, μM
1
10
100
1000
10000
Air benzene, ppm
0.001
0.01
0.1
1
10
100
Concentration of CA, μM
1
10
100
1000
A. MA
B. SPMA
C. PH
D. CA
Air benzene, ppm
0.001
0.01
0.1
1
10
100
Concentration of HQ, μM
1
10
100
1000
E. HQ
Air benzene, ppm
0.001
0.01
0.1
1
10
100
Concentration of HQ, μM
1
10
100
1000
E. HQ
Background 
levels
Kim et al., CEBP, 2006
S. M. Rappaport
13
Effects of Covariates 
[GLM+NS]
No effect of:
• Alcohol
•Toluene co-exposure
  
  
  
Parameter
  
Metabolite 
Adj.R2 
Covariate 
Estimate 
p-value 
Intercept 
1.15 
<0.0001 
Age 
-0.016 
0.001 
MA 
0.812 
Sex (male)
-0.215 
0.013 
Intercept 
-6.04 
<0.0001 
Age 
-0.016 
0.086 
SPMA 
0.744 
Sex (male)
-0.347 
0.032 
Intercept 
4.22 
<0.0001 
Age 
-0.011 
0.016 
PH 
0.608 
Sex 
-0.198 
0.009 
Intercept 
2.66 
<0.0001 
BMI 
-0.022 
0.028 
Sex (male)
-0.243 
0.007 
CA 
0.506 
Smoking 
0.323 
0.001 
Intercept 
1.96 
<0.0001 
Age 
-0.013 
0.003 
Sex (male)
-0.221 
0.019 
HQ 
0.689 
Smoking 
0.338 
0.001 
 
Sex: females produce 
more metabolites 
than males
Age: metabolite 
production reduced 1-
2%/year of life
Smoking: Cigarette 
smoke contains HQ 
and CA
Kim et al., CEBP, 2006
S. M. Rappaport
14
Dose-Related Metabolism of Benzene
0
1000
2000
3000
4000
total metabolites, umol/l
0
10
20
30
40
50
60
air benzene, ppm
Predicted levels of total metabolites (background adjusted, 
female subject, 29 y of age)
0
100
200
300
400
500
total metabolites, umol/l
0
1
2
3
4
5
air benzene, ppm
9-fold reduction 
in slope
S. M. Rappaport
15
benzene
O
N
S
CH3
C
CH
CH2
COOH
Oxepin
O
conjugate
via GST
S-phenylmercapturic acid
COOH
HOOC
CHO
OCH
E,E-Muconic Acid
OH
Phenol
OH
Hydroquinone
O
O
1,4-Benzoquinone
OH
OH
HO
OH
OH
Catechol
O
OH
OH
Benzene Diol Expoxide
O
O
Benzene dihydrodiol
OH
1,2-Benzoquinone
CYP
CYP2E1
Nonezymatic 
Rearrangement
Epoxide Hydrolase
CYP
dihyrodiol dehydrogenase
CYP2E1
HO
OH
E,E-Muconaldehyde
1,2,4-trihydroxybenzene
O
Benzene Oxide
CYP2E1
Effects of Metabolism Genes
CYPs
S. M. Rappaport
16
benzene
O
N
S
CH3
C
CH
CH2
COOH
Oxepin
O
conjugate
via GST
S-phenylmercapturic acid
COOH
HOOC
CHO
OCH
E,E-Muconic Acid
OH
Phenol
OH
Hydroquinone
O
O
1,4-Benzoquinone
OH
OH
HO
OH
OH
Catechol
O
OH
OH
Benzene Diol Expoxide
O
O
Benzene dihydrodiol
OH
1,2-Benzoquinone
CYP
CYP2E1
Nonezymatic 
Rearrangement
Epoxide Hydrolase
CYP
dihyrodiol dehydrogenase
CYP2E1
HO
OH
E,E-Muconaldehyde
1,2,4-trihydroxybenzene
O
Benzene Oxide
CYP2E1
Effects of Metabolism Genes
EPHX
NQ01
MPO
NQ01
MPO
GSTs
S. M. Rappaport
17
benzene
O
N
S
CH3
C
CH
CH2
COOH
Oxepin
O
conjugate
via GST
S-phenylmercapturic acid
COOH
HOOC
CHO
OCH
E,E-Muconic Acid
OH
Phenol
OH
Hydroquinone
O
O
1,4-Benzoquinone
OH
OH
HO
OH
OH
Catechol
O
OH
OH
Benzene Diol Expoxide
O
O
Benzene dihydrodiol
OH
1,2-Benzoquinone
CYP
CYP2E1
Nonezymatic 
Rearrangement
Epoxide Hydrolase
CYP
dihyrodiol dehydrogenase
CYP2E1
HO
OH
E,E-Muconaldehyde
1,2,4-trihydroxybenzene
O
Benzene Oxide
CYP2E1
Effects of Metabolism Genes
NQ01 & 
MPO
NQ01
MPO
NQ01
MPO
S. M. Rappaport
18
Magnitudes of Genetic Effects and Gene-
 
Environment Interactions
Kim et al., PGEN, in press
Several significant 
effects, most in 
expected directions
Most effects are small 
(< 3-fold)
SNP EFFECTS ON BENZENE METABOLITES  
Ratio of (Var:Var)/(Wild:Wild) 
Air concentration (ppm) 
Metabolite 
SNP 
0.1 
1 
10 
100 
CYP2E1 
0.941
0.666 
0.472 
0.333 
MA 
NQO1*2  
0.976
0.832 
0.708 
0.603 
CYP2E1  
0.675
0.619 
0.567 
0.519 
EPHX1  
1.00 
1.26 
1.59 
2.01 
GSTT1 
0.328
0.236 
0.17 
0.122 
GSTM1 
0.554
0.554 
0.554 
0.554 
NQO1*2 (Nonsmokers) 
0.614
0.524 
0.448 
0.382 
SPMA 
NQO1*2 (Smokers) 
1.74 
1.48 
1.27 
1.08 
CYP2E1  
0.75 
0.542 
0.392 
0.283 
NQO1*2 (Nonsmokers) 
0.714
0.714 
0.714 
0.714 
PH 
NQO1*2 (Smokers) 
1.22 
1.22 
1.22 
1.22 
EPHX1  
1.15 
1.15 
1.15 
1.15 
NQO1*2  
0.902
0.789 
0.69 
0.603 
EPHX1 (Nonsmokers) 
1.29 
1.10 
0.938 
0.8 
CA 
EPHX1 (Smokers) 
0.685
0.584 
0.498 
0.425 
CYP2E1  
0.692
0.518 
0.389 
0.291 
HQ 
NQO1*2  
0.849
0.849 
0.849 
0.849 
 
S. M. Rappaport
19
Magnitudes of Genetic Effects and Gene-
 
Environment Interactions
Kim et al., PGEN, in press
Most effects vary with 
conc. due to saturable 
metabolism and gene-
environment 
interactions
SNP EFFECTS ON BENZENE METABOLITES  
Ratio of (Var:Var)/(Wild:Wild) 
Air concentration (ppm) 
Metabolite 
SNP 
0.1 
1 
10 
100 
CYP2E1 
0.941
0.666 
0.472 
0.333 
MA 
NQO1*2  
0.976
0.832 
0.708 
0.603 
CYP2E1  
0.675
0.619 
0.567 
0.519 
EPHX1  
1.00 
1.26 
1.59 
2.01 
GSTT1 
0.328
0.236 
0.17 
0.122 
GSTM1 
0.554
0.554 
0.554 
0.554 
NQO1*2 (Nonsmokers) 
0.614
0.524 
0.448 
0.382 
SPMA 
NQO1*2 (Smokers) 
1.74 
1.48 
1.27 
1.08 
CYP2E1  
0.75 
0.542 
0.392 
0.283 
NQO1*2 (Nonsmokers) 
0.714
0.714 
0.714 
0.714 
PH 
NQO1*2 (Smokers) 
1.22 
1.22 
1.22 
1.22 
EPHX1  
1.15 
1.15 
1.15 
1.15 
NQO1*2  
0.902
0.789 
0.69 
0.603 
EPHX1 (Nonsmokers) 
1.29 
1.10 
0.938 
0.8 
CA 
EPHX1 (Smokers) 
0.685
0.584 
0.498 
0.425 
CYP2E1  
0.692
0.518 
0.389 
0.291 
HQ 
NQO1*2  
0.849
0.849 
0.849 
0.849 
 
S. M. Rappaport
20
Magnitudes of Genetic Effects and Gene-
 
Environment Interactions
Kim et al., PGEN, in press
Evidence of gene-smoking 
interactions
SNP EFFECTS ON BENZENE METABOLITES  
Ratio of (Var:Var)/(Wild:Wild) 
Air concentration (ppm) 
Metabolite 
SNP 
0.1 
1 
10 
100 
CYP2E1 
0.941
0.666 
0.472 
0.333 
MA 
NQO1*2  
0.976
0.832 
0.708 
0.603 
CYP2E1  
0.675
0.619 
0.567 
0.519 
EPHX1  
1.00 
1.26 
1.59 
2.01 
GSTT1 
0.328
0.236 
0.17 
0.122 
GSTM1 
0.554
0.554 
0.554 
0.554 
NQO1*2 (Nonsmokers) 
0.614
0.524 
0.448 
0.382 
SPMA 
NQO1*2 (Smokers) 
1.74 
1.48 
1.27 
1.08 
CYP2E1  
0.75 
0.542 
0.392 
0.283 
NQO1*2 (Nonsmokers) 
0.714
0.714 
0.714 
0.714 
PH 
NQO1*2 (Smokers) 
1.22 
1.22 
1.22 
1.22 
EPHX1  
1.15 
1.15 
1.15 
1.15 
NQO1*2  
0.902
0.789 
0.69 
0.603 
EPHX1 (Nonsmokers) 
1.29 
1.10 
0.938 
0.8 
CA 
EPHX1 (Smokers) 
0.685
0.584 
0.498 
0.425 
CYP2E1  
0.692
0.518 
0.389 
0.291 
HQ 
NQO1*2  
0.849
0.849 
0.849 
0.849 
 
S. M. Rappaport
21
Conclusions
Benzene is metabolized more efficiently at air 
concentrations below 1 ppm
 
(about 9-fold for total 
metabolites)
–
 
Observed in two independent Chinese studies using two 
different biomarkers of exposure (protein adducts and 
urinary metabolites) 
Risk assessments based upon linear models may 
underestimate risks at low exposure levels 
Metabolism varies with age and differs between males 
and females
Metabolizing genes and gene-environment interactions 
have detectable but small effects on metabolite 
production
S. M. Rappaport
22
Conclusions
Biomarkers can be used in observational studies to 
elucidate effects of metabolism and other 
phenomena of interest
IF exposures are carefully measured in the same 
subjects
With Thanks To:
S.M. Rappaport
23
•
 
UNC
–
 
Sungkyoon
 
Kim
–
 
Suramya
 
Waidyanatha
–
 
Karen Yeowell-
 
O’Connell 
–
 
Brent Johnson
•
 
NCI
–
 
Nat Rothman 
–
 
Roel
 
Vermeulen
–
 
Qing Lan
–
 
Stephen Chanock
•
 
NYU
–
 
Qinshan
 
Qu
–
 
Roy Shore
–
 
Beverley Cohen
•
 
UC-Berkeley
–
 
Martyn
 
Smith
–
 
Luoping
 
Zhang
•
 
IOM  (Beijing)
–
 
Guilan
 
Li
–
 
Songnian
 
Yin
Work supported by NIEHS 
and HEI
